SCIVISION BIOTECH INC. of Kaohsiung at MEDICA 2021 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option


No. 1, S. 1st Rd., Cianjhen Dist.,, 806011 Kaohsiung
Telephone +886 7 8232258
Fax +886 7 8232295

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

This company is co-exhibitor of
Taiwan External Trade Development Council (TAITRA)

Hall map

MEDICA 2021 hall map (Hall 16): stand C36

Fairground map

MEDICA 2021 fairground map: Hall 16


Sung Soraya

International Sales

+8867-8232258 ext:3205


Please log in

You must be logged in to use matchmaking

Please log in for matchmaking

Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.

Let's get started!

Welcome to Matchmaking. Would you like to get in touch with ?

Our range of products

Product categories

  • 01  Imaging and diagnostics / medical equipment and devices
  • 01.05  Implants and prostheses
  • 01.05.03  Orthopaedic implants and prostheses

Orthopaedic implants and prostheses

About us

Company portrait

SciVision Biotech Inc., founded in 2001, is now a public company listed at Taiwan Stock Exchang (Stock symbol : 1786) SciVision Biotech Inc. manufactures Hyaluronic acid products by using own-developed Cross-linked Hyaluronic Acid Platform (CHAP) to make the characteristics of Hyaluronic acid products be precisely controllable, and can be widely used in the production of cross-

linked Hyaluronic acid products with different types and physical properties. The technology of Cross-linked Hyaluronic Acid Platform (CHAP) established the leading position of SciVision Biotech Inc. in the field of medical grade Hyaluronic acid products.
The population structures of both developed and developing countries are gradually moving towards an aging society. The pursuit of beauty and health, as well as the demand for medical care of degenerative diseases has increased day by day. The main products of our company are Hyaluronic acid dermal fillers (for medical and cosmetic surgical use), Hyaluronic acid anti-adhesion gels (for surgical use) and Hyaluronic acid viscosupplement (for treatment of knee osteoarthritis). The three Hyaluronic acid products are high-

level medical devices that cater to the commercial possibilities for next 10-year growth. Today, our company has gradually increased the technology scale and is being devoted to the health and beauty fields, to create a better vision and reach the human’s aesthetic realm

SciVision Biotech acquired a nearly 20,000 square meter site located in Kaohsiung Cianjhen Technology Industrial Park for the construction of a new manufacturing facility to accommodate the growing production needs. The facility was GMP certified, and was constructed based on FDA standard, fully equipped with advanced automatic equipment.
We work with pharmaceutical and specialty companies worldwide to develop long-term competitiveness. SciVision’s vision is to contribute its accumulated technologies and experience for the benefit of all humankind, to develop high-quality, high-efficiency products, to improve the health and the quality of life of the public, and to become a leading company in Taiwan’s biotech industry, while continue our growth in the global market